| Abstrakt: |
Researchers at the RIKEN Center for Integrative Medical Sciences in Yokohama, Japan, have developed a new genotype-phenotype linked antibody screening system to rapidly isolate therapeutic or diagnostic antibodies. This system allows for the quick identification of influenza cross-reactive antibodies with high affinity from immunized mice within 7 days. The research, funded by the Japan Society For The Promotion of Science and Riken, aims to enhance the development of antibodies for disease therapy and diagnosis, particularly during pandemics. For more information, readers can access the full article in eLife. [Extracted from the article] |
